Vicki L. Sato, a director at Vir Biotechnology, Inc. ($VIR), sold shares on the open market 12 times over the past year, totaling $1.6 million. Her most recent sale occurred on March 2, 2026. These sales rank her 3,875th among 11,678 insiders by value sold, below the average of $8.6 million across about 6.4 transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 22000 | $9.07 | 1,100,391.0000 | 139,125,032 | 1.96% | 0.02% |
| March 2, 2026 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 21800 | $9.50 | 1,122,591.0000 | 139,125,032 | 1.90% | 0.02% |
| March 2, 2026 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 200 | $9.98 | 1,122,391.0000 | 139,125,032 | 0.02% | 0.00% |
| Feb. 24, 2026 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 200 | $10.26 | 1,144,391.0000 | 139,125,032 | 0.02% | 0.00% |
| Feb. 24, 2026 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | M | Common Stock | 42377 | $1.49 | 1,186,768.0000 | 139,125,032 | 3.70% | 0.03% |
| Feb. 24, 2026 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | M | Stock Option (Right to Buy) | 42377 | $0.00 | 0.0000 | 139,125,032 | 100.00% | 0.03% |
| Feb. 24, 2026 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 42177 | $9.75 | 1,144,591.0000 | 139,125,032 | 3.55% | 0.03% |
| Feb. 2, 2026 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 22000 | $7.71 | 1,144,391.0000 | 139,125,032 | 1.89% | 0.02% |
| Jan. 2, 2026 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 22000 | $5.93 | 1,166,391.0000 | 139,125,032 | 1.85% | 0.02% |
| Dec. 1, 2025 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 22000 | $6.00 | 1,188,391.0000 | 139,125,032 | 1.82% | 0.02% |
| Nov. 3, 2025 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 22000 | $5.64 | 1,210,391.0000 | 139,125,032 | 1.79% | 0.02% |
| Oct. 1, 2025 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 22000 | $5.84 | 1,232,391.0000 | 137,143,286 | 1.75% | 0.02% |
| Sept. 2, 2025 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 22000 | $4.99 | 1,254,391.0000 | 137,143,286 | 1.72% | 0.02% |
| Aug. 1, 2025 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 22000 | $4.99 | 1,276,391.0000 | 137,143,286 | 1.69% | 0.02% |
| July 1, 2025 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 22000 | $5.10 | 1,298,391.0000 | 137,143,286 | 1.67% | 0.02% |
| June 18, 2025 | Allogene Therapeutics, Inc. | $ALLO | SATO VICKI L | Director | A | Stock Option (Right to buy) | 144400 | $0.00 | 144,400.0000 | 217,264,738 | 9999.99% | 0.07% |
| May 30, 2025 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | A | Common Stock | 8000 | $0.00 | 1,320,391.0000 | 137,143,286 | 0.61% | 0.01% |
| May 30, 2025 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 137,143,286 | 9999.99% | 0.01% |
| Jan. 8, 2025 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 10960 | $12.52 | 1,312,391.0000 | 0 | 0.83% | 0.00% |
| Jan. 2, 2025 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 3080 | $20.91 | 107,976.0000 | 164,473,772 | 2.77% | 0.00% |
| Nov. 7, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 1020 | $30.00 | 111,056.0000 | 169,456,988 | 0.91% | 0.00% |
| Nov. 1, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 3080 | $27.07 | 112,076.0000 | 169,456,988 | 2.67% | 0.00% |
| Sept. 13, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 1020 | $30.00 | 115,156.0000 | 137,370,897 | 0.88% | 0.00% |
| Sept. 3, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 100 | $25.37 | 116,176.0000 | 137,370,897 | 0.09% | 0.00% |
| Sept. 3, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 2980 | $24.99 | 116,276.0000 | 137,370,897 | 2.50% | 0.00% |
| July 1, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 100 | $22.86 | 119,256.0000 | 137,370,897 | 0.08% | 0.00% |
| July 1, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 2980 | $22.12 | 119,356.0000 | 137,370,897 | 2.44% | 0.00% |
| June 5, 2024 | Allogene Therapeutics, Inc. | $ALLO | SATO VICKI L | Not found | A | Stock Option (Right to buy) | 95541 | $0.00 | 95,541.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Allogene Therapeutics, Inc. | $ALLO | SATO VICKI L | Not found | A | Common Stock | 61475 | $0.00 | 162,575.0000 | 0 | 60.81% | 0.00% |
| May 31, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | A | Common Stock | 5967 | $0.00 | 122,336.0000 | 137,370,897 | 5.13% | 0.00% |
| May 31, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | A | Stock Option (right to buy) | 17901 | $0.00 | 17,901.0000 | 137,370,897 | 9999.99% | 0.01% |
| May 30, 2024 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | A | Common Stock | 8000 | $0.00 | 1,323,351.0000 | 0 | 0.61% | 0.00% |
| May 30, 2024 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 1674 | $20.39 | 116,369.0000 | 137,370,897 | 1.42% | 0.00% |
| April 15, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 1666 | $18.29 | 118,043.0000 | 137,370,897 | 1.39% | 0.00% |
| March 15, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 1666 | $20.10 | 119,709.0000 | 137,370,897 | 1.37% | 0.00% |
| Feb. 15, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 1666 | $18.37 | 121,375.0000 | 137,370,897 | 1.35% | 0.00% |
| Jan. 16, 2024 | Denali Therapeutics Inc. | $DNLI | SATO VICKI L | Director | S | Common Stock | 1666 | $18.42 | 123,041.0000 | 137,370,897 | 1.34% | 0.00% |
| June 30, 2023 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 18000 | $24.66 | 1,315,351.0000 | 0 | 1.35% | 0.00% |
| June 13, 2023 | Allogene Therapeutics, Inc. | $ALLO | SATO VICKI L | Not found | A | Common Stock | 59649 | $0.00 | 101,100.0000 | 0 | 143.90% | 0.00% |
| June 13, 2023 | Allogene Therapeutics, Inc. | $ALLO | SATO VICKI L | Not found | A | Stock Option (Right to Buy) | 23224 | $0.00 | 23,224.0000 | 0 | 9999.99% | 0.00% |
| May 22, 2023 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | A | Common Stock | 6027 | $0.00 | 1,333,351.0000 | 0 | 0.45% | 0.00% |
| May 22, 2023 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | A | Stock Option (Right to Buy) | 12054 | $0.00 | 12,054.0000 | 0 | 9999.99% | 0.00% |
| March 8, 2023 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 17935 | $22.59 | 1,327,324.0000 | 0 | 1.33% | 0.00% |
| Feb. 8, 2023 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 627 | $29.00 | 1,345,259.0000 | 0 | 0.05% | 0.00% |
| Feb. 8, 2023 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 17288 | $28.35 | 1,345,886.0000 | 0 | 1.27% | 0.00% |
| Jan. 9, 2023 | Vir Biotechnology, Inc. | $VIR | SATO VICKI L | Director | S | Common Stock | 17915 | $25.83 | 1,363,174.0000 | 0 | 1.30% | 0.00% |